A CRC cell line (RKO) in which all of the Wnt antagonist genes were methylated served as a positive control, while another CRC cell line (DKO2) in which the DNMT1 and DNMT3B loci were genetically disrupted served as a negative control (Figure 1B). This evidence concerns the gene DNMT1 and colorectal carcinoma.